Get a complimentary sample of HealthQuant's Next-Generation Congress Intelligence Report, analyzing the clinical findings, physician conversations, and KOL activity that shaped the urothelial cancer landscape at ESMO 2026. And unlike traditional summaries, we identify the findings that matter, the physicians shaping the conversation, and the implications for your strategy.
Designed for Medical Affairs teams, our reports can be customized to your therapeutic area, brand, competitors, and strategic priorities.
Get your complimentary report—fill out the form to download.